Cognition Therapeutics Inc. (CGTX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Cognition Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$0.75
−1.33% today
Market cap
$72M
Overall quality
45/100
Kronos AI 30-day
—
Cognition Therapeutics Inc. (CGTX) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $72M. It trades at $0.75, down 1.33% today. Its overall quality score is 45 out of 100, ranked against the whole US market. 1 analysts' average target of $3.00 implies +300.0% from today's price.
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $3.00 |
| Low – high | $3.00 – $3.00 |
| Analysts | 1 |
| Upside to average | +300.0% |
Kronos AI 30-day forecast
No forecast for this listing.
Quality scores
| Profitability | 38 |
| Solvency | 57 |
| Growth | 41 |
| Overall | 45 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.